1. Home
  2. CATX

as 09-17-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Founded: 1983 Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 239.0M IPO Year: N/A
Target Price: $12.90 AVG Volume (30 days): 696.8K
Analyst Decision: Strong Buy Number of Analysts: 11
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.32 EPS Growth: N/A
52 Week Low/High: $1.60 - $14.19 Next Earning Date: 11-11-2025
Revenue: $1,235,000 Revenue Growth: -15.64%
Revenue Growth (this year): -22.08% Revenue Growth (next year): -31.57%

CATX Daily Stock ML Predictions

Share on Social Networks: